Monthly Archives: May 2018
New Study Finds that Lowering Cholesterol Improves Immunotherapy
May 19, 2018 (Medical News Today)
This study was published in the Journal of Experimental Medicine. It discovered that when cholesterol levels are decreased, cancer...
Combo of Chemo & Immunotherapy Determined Feasible in Metastatic Bladder Cancer
April 11, 2018 (HealthDay News)
One-year overall survival of 61 percent for gemcitabine and cisplatin plus ipilimumab
Gemcitabine and cisplatin (GC) plus ipilimumab is associated with...
CAR T-Cell Immunotherapy Named Clinical Advance of the Year by ASCO
In January, ASCO published its 13th annual report in Clinical Cancer Advances 2018, and named chimeric antigen receptor (CAR) T-cell immunotherapy as its Advance...
CAR T-Cell Therapy HCP Guide – Future Implications for CAR T-Cell Therapy
What's Next for CAR T-Cell Therapy?
Top issues for researchers and clinicians utilizing CAR T-cell therapy include:
Shortening the manufacturing time and vein-to-vein time, scaling...
